focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCPE.L Regulatory News (CCPE)

  • There is currently no data for CCPE

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CVC Credit Partners Market Update Note

16 Mar 2020 07:00

RNS Number : 1579G
CVC Credit Partners European Opps.
16 March 2020
 

16 March 2020

 

CVC Credit Partners European Opportunities Limited

(a closed-ended investment company incorporated in Jersey with registration number 112635)

Registered Office: IFC 1, The Esplanade, St Helier, Jersey, JE1 4BP

 

 

CVC Credit Partners Market Update Note

 

 

CVC Credit Partners European Opportunities Limited ("the Company") announces the publication of the following market update note by CVC Credit Partners Investment Management Limited ("CVC Credit Partners"), as Investment Vehicle Manager to the Company. This update will also be available on the Company's website www.ccpeol.com.

 

 

Enquiries:

 

BNP Paribas Securities Services S.C.A. Jersey Branch

Tel: +44 (0) 1534 709181/813820

 

 

CVC Credit Partners

 

Market Update Note: 13th March 2020

 

Following our 2nd March note addressing the initial impact of the Coronavirus outbreak, global credit markets have continued to experience significant volatility in the past weeks, driven by (i) the continued expansion of the Coronavirus epidemic on a global scale, and (ii) the break-up of the OPEC+ alliance and downward pressure on crude oil pricing.

 

As at 12th March, leveraged loan markets month-to-date ("MTD") were down -6.22% in Europe and -6.41% in the U.S., and year-to-date ("YTD") -6.71% and -7.18%, respectively. In HY, the impact continued to be more acute with MTD Europe down -7.89% and U.S. -8.27%, and YTD at -9.45% and -9.95%, respectively. The dislocation seen in credit markets, however, has been dwarfed by that seen across equity markets with the FTSE100 index returning -20% MTD and -31% YTD.

 

Current market volatility and uncertainty has led investors to "safe haven" assets, driving the U.S. 10-year and 30-year treasury yields below 1% for the first time, and the UK 10-year and 30-year GILTs to near-zero this week.

 

As we expected in our prior note, the impact on global credit markets has been supported by central bank policies and government-led fiscal stimulus globally. U.S. and UK central banks reduced rates this week by 50bps to record lows and the ECB announced €120bn of bond purchases and additional bank loans. Fiscal stimulus measures were announced globally that included tax breaks, debt relief measures and direct funding support for businesses.

 

In light of these developments, our base case scenario remains a six to nine month disruption period for issuers, however, this could be further extended depending on the development of the epidemic in the coming weeks and into Q2.

 

Portfolio Impact

 

The impact of the above events is being closely monitored across the portfolio, and we are actively risk managing individual positions that we believe could be most exposed to these events. This includes pre-emptively divesting positions in issuers with material Italian operations, issuers in the transportation, leisure and logistics sectors, and structured finance positions subject to higher volatility, and utilising sale proceeds to build up cash positions.

 

We remain in active dialogue with issuers of credit positions we currently hold, and today the portfolio remains conservatively positioned with regards to industries and regions most severely affected by recent events: (i) zero exposure to oil and gas and related sectors (ii)

 

We further believe the current environment will create attractive investment opportunities, particularly in the credit opportunities segment driven by the technical dislocation across this asset class. However, we remain cautious in adding new positions to the portfolio, and only where we have real conviction the issuer is well positioned in light of current events.

 

As the situation continues to develop in the coming weeks, we will provide further updates, and are of course very happy to speak to any investors directly to discuss these implications on the strategy.

 

Andrew Davies

Partner, Head of Europe,

Senior Portfolio Manager

 

Certain information contained in this Communication constitutes forward-looking statements. Any forward-looking statements or results in this Communication are based upon current assumptions, may be simplified and may depend on events outside CVC Credit Partners' control. Changes to any assumptions may have a material impact on any forecasts, projections or results. Actual results may therefore be materially different from any forecast, opinion, projection or result in this Communication. Any opinions expressed herein represent the current, good faith views CVC Credit Partners at the time of publication and are provided for limited purposes, are not definitive investment advice, and should not be relied on as such. The information presented herein has been developed internally and/or obtained from sources believed to be reliable; however, CVC Credit Partners does not guarantee the accuracy, adequacy or completeness of such information. Predictions, opinions, and other information contained in this communication are subject to change continually and without notice of any kind and may no longer be true after the date indicated. Any forward-looking statements speak only as of the date they are made, and CVC Credit Partners assumes no duty to and does not undertake to update forward-looking statements. Forward-looking statements are subject to numerous assumptions, risks and uncertainties, which change over time. Actual results could differ materially from those anticipated in forward-looking statements. Investors should keep in mind that the securities and loan markets are volatile and unpredictable. All data included herein is as at 12 March 2020 and specific data sources can be made available on request.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDGPUUUWUPUGQW
Date   Source Headline
13th Jun 20223:34 pmRNSChange of Name
9th Jun 20224:50 pmRNSNet Asset Value Weekly to 01 June 2022
1st Jun 20224:46 pmRNSNet Asset Value Weekly to 27 May 2022
1st Jun 202212:43 pmRNSTotal Voting Rights
26th May 20225:22 pmRNSNet Asset Value Weekly to 20 May 2022
19th May 20223:31 pmRNSOrdinary Share Conversion June 2022
19th May 20222:10 pmRNSNet Asset Value Weekly to 13 May 2022
19th May 202211:51 amRNSPublication of the April 2022 Monthly Report
18th May 20224:44 pmRNSDividend Declaration
18th May 20224:43 pmRNSResult of AGM
17th May 20223:19 pmRNSTotal Voting Rights
16th May 20224:31 pmRNSNet Asset Value Month End 29 Apr 2022
13th May 20225:00 pmRNSNet Asset Value Weekly to 06 May 2022
10th May 20223:39 pmRNSMarch 2022 Tender
5th May 20223:24 pmRNSNet Asset Value Weekly to 29 Apr 2022
3rd May 202211:21 amRNSTotal Voting Rights
29th Apr 20222:33 pmRNSTotal Voting Rights
28th Apr 20225:48 pmRNSNet Asset Value Weekly to 22 Apr 2022
28th Apr 20223:43 pmRNSInvestor Call
27th Apr 202212:11 pmRNSHolding(s) in Company
25th Apr 20223:16 pmRNSApril 2022 Share Conversion
22nd Apr 20221:38 pmRNSPublication of the March 2022 Monthly Report
22nd Apr 20221:17 pmRNSNet Asset Value Weekly to 14 Apr 2022
22nd Apr 202210:00 amRNSNotice of AGM
21st Apr 202211:32 amRNSHolding(s) in Company
20th Apr 20223:13 pmRNSMarch 2022 Tender Price
19th Apr 20224:45 pmRNSOrdinary Share Conversion May 2022
14th Apr 20223:58 pmRNSNet Asset Value Weekly to 08 Apr 2022
14th Apr 20223:22 pmRNSNet Asset Value Month End 31 Mar 2022
7th Apr 202212:13 pmRNSNet Asset Value Weekly to 01 Apr 2022
6th Apr 20224:47 pmRNSMarch 2022 Quarterly Tender
6th Apr 202210:17 amRNSAnnual Financial Report
30th Mar 20224:50 pmRNSNet Asset Value Weekly to 25 Mar 2022
24th Mar 20222:49 pmRNSNet Asset Value Weekly to 18 Mar 2022
21st Mar 20224:30 pmRNSOrdinary Share Conversion April 2022
17th Mar 202212:28 pmRNSNet Asset Value Weekly to 11 Mar 2022
16th Mar 20229:01 amRNSPublication of the February 2022 Monthly Report
14th Mar 20221:21 pmRNSNet Asset Value Month End 28 Feb 2022
9th Mar 20224:23 pmRNSNet Asset Value Weekly to 04 Mar 2022
9th Mar 20221:01 pmRNSStrategic Review Update
7th Mar 20224:17 pmRNSHolding(s) in Company
3rd Mar 202212:59 pmRNSNet Asset Value Weekly to 25 Feb 2022
1st Mar 20223:02 pmRNSTotal Voting Rights
24th Feb 20225:31 pmRNSNet Asset Value Weekly to 18 Feb 2022
21st Feb 20221:55 pmRNSPublication of the January 2022 Monthly Report
18th Feb 20224:34 pmRNSHolding(s) in Company
18th Feb 20223:39 pmRNSNet Asset Value Weekly to 11 Feb 2022
18th Feb 20222:28 pmRNSDirector Declaration
18th Feb 202212:04 pmRNSHolding(s) in Company
16th Feb 20225:40 pmRNSNet Asset Value Month End 31 Jan 2022

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.